← All stocks

Calidi Biotherapeutics, Inc.

CLDI Net selling
CIK 0001855485 #5519 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.24K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.24K
1 of 1 sales
Net
−$1.24K
−$1.24K against sales at will

By person

6 insiders · 1 transaction
0.1×

Eric Poma holds only 0.1 times base salary in stock. $36.38K of shares against $358.04K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Poma last reported holding, valued at $1.46, the price Common Stock was last bought or sold at on the open market here, on 12 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Camaisa Allan
Director
$1.24K (1)
−$1.24K
143,664
$209.03K
+70.3%
Leftwich Scott
Director
130,650
$190.10K
Schoeneck James A
Director
76,134
$110.77K
+6,614%
Stewart Alan R.
Director
28,976
$42.16K
+78.8%
Poma Eric E
Chief Executive Officer
25,000
$36.38K
Jackson Andrew C.
Chief Financial Officer
2,500
$3.64K

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 2,584,184 to 28,467,580 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Camaisa Allan
12 Dec 2025
Director
Sell indirect
850
$1.46
$1.24K

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 Sep 2022